Brief: Novartis Announces Commencement Of Tender Offer To Acquire Regulus Therapeutics

Regulus Therapeutics

27/05/2025 12:58

May 27 (Reuters) - Novartis AG NOVN.S:

NOVARTIS ANNOUNCES COMMENCEMENT OF TENDER OFFER TO ACQUIRE REGULUS THERAPEUTICS

NOVARTIS AG - OFFER INCLUDES $7.00 CASH PER SHARE PLUS CONTINGENT VALUE RIGHT

NOVARTIS AG - PAR VALUE $0.001 PER SHARE

NOVARTIS AG - OFFER SUBJECT TO CUSTOMARY CONDITIONS INCLUDING HART-SCOTT-RODINO ACT

NOVARTIS AG - IN EXCHANGE FOR (I) $7.00 IN CASH PER SHARE

NOVARTIS AG - OFFER WILL EXPIRE AT ONE MINUTE PAST 11:59 P.M., NEW YORK CITY TIME, ON JUNE 24, 2025, UNLESS OFFER IS OTHERWISE EXTENDED OR EARLIER TERMINATED

Source text: ID:nGNE4jZJfZ

Further company coverage: NOVN.S

 (Gdansk Newsroom)

 (((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600);))